Literature DB >> 14577601

Atrial natriuretic hormone prohormone gene expression in cardiac and extra-cardiac tissues of diabetic Goto-Kakizaki rats.

William R Gower1, Gloria I San Miguel, Gay M Carter, Imran Hassan, Robert V Farese, David L Vesely.   

Abstract

The present investigation was designed to determine if the mechanism for the increased atrial natriuretic peptides within the circulation of diabetic animals involves atrial natriuretic hormone prohormone (proANH) gene expression upregulation. The tissue specificity of this potential upregulation of the proANH gene was investigated in a spontaneous model of type 2 diabetes, i.e. the Goto-Kakizaki (GK) rat with comparison to age-matched non-diabetic Wistar rats from which the GK colony was originally derived. Reverse transcription-polymerase chain reaction revealed that proANH gene expression was increased 3.1-fold in the left heart ventricle, 5-fold in lung, 2-fold in kidney, 3-fold within mucosa and 1.8-fold within muscle of gastric antrum (p < 0.05 for each) of GK rats compared to Wistar rats. There was no significant increase in proANH gene expression in atria and right ventricle of the heart of GK rats compared to Wistars. These results indicate that steady-state ANH prohormone mRNA levels increase within the left ventricle and extracardiac tissues in type 2 diabetic animals. This enhanced gene expression is a functional increase with its expressed proteins (4 peptide hormones; ANPs) increasing 2-6 fold within the circulation of GKs. The greater increase in proANH messenger RNA in the extracardiac tissues compared to the amount of increase within the heart and the greater tissue mass of these combined extra cardiac tissues suggests the majority of the increase in ANPs within the circulation of diabetics is secondary to increased synthesis in extracardiac tissues. This also suggests that there is a systemic regulatory mechanism of proANH gene expression not only within the heart but also within the lung, gastrointestinal tract and kidney. Diabetes is the first disease in which there is more upregulation of ANH prohormone in extracardiac tissues compared to upregulation within the heart itself.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14577601     DOI: 10.1023/a:1025552029296

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  41 in total

1.  Atrial natriuretic prohormone peptides 1-30, 31-67, and 79-98 vasodilate the aorta.

Authors:  D L Vesely; J S Norris; J M Walters; R R Jespersen; D A Baeyens
Journal:  Biochem Biophys Res Commun       Date:  1987-11-13       Impact factor: 3.575

2.  Evidence supporting a physiological role for proANP-(1-30) in the regulation of renal excretion.

Authors:  J R Dietz; D Y Scott; C S Landon; S J Nazian
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-05       Impact factor: 3.619

3.  Hemodynamic and renal effects of ProANF31-67 in hypertensive rats.

Authors:  D Villarreal; G P Reams; A Taraben; R H Freeman
Journal:  Proc Soc Exp Biol Med       Date:  1999-07

4.  Increased atrial natriuretic peptide mRNA expression in the kidney of diabetic rats.

Authors:  S J Shin; Y J Lee; M S Tan; T J Hsieh; J H Tsai
Journal:  Kidney Int       Date:  1997-04       Impact factor: 10.612

5.  Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans.

Authors:  D L Vesely; M A Douglass; J R Dietz; W R Gower; M T McCormick; G Rodriguez-Paz; D D Schocken
Journal:  Circulation       Date:  1994-09       Impact factor: 29.690

6.  Insulin-induced activation of glycerol-3-phosphate acyltransferase by a chiro-inositol-containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats.

Authors:  R V Farese; M L Standaert; K Yamada; L C Huang; C Zhang; D R Cooper; Z Wang; Y Yang; S Suzuki; T Toyota
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

7.  Atrial natriuretic peptide (ANP): a study of ANP and its mRNA in cardiocytes, and of plasma ANP levels in non-obese diabetic mice.

Authors:  H Mifune; S Suzuki; J Honda; Y Kobayashi; Y Noda; Y Hayashi; K Mochizuki
Journal:  Cell Tissue Res       Date:  1992-02       Impact factor: 5.249

8.  Release of kaliuretic peptide during immersion-induced central hypervolemia in healthy humans.

Authors:  D L Vesely; P Norsk; W R Gower; S Chiou; M Epstein
Journal:  Proc Soc Exp Biol Med       Date:  1995-05

9.  Identification of atrial natriuretic factor gene transcripts in the central nervous system of the rat.

Authors:  D G Gardner; G P Vlasuk; J D Baxter; J C Fiddes; J A Lewicki
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

10.  Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method.

Authors:  H Wong; W D Anderson; T Cheng; K T Riabowol
Journal:  Anal Biochem       Date:  1994-12       Impact factor: 3.365

View more
  2 in total

1.  Localization of ANP-synthesizing cells in rat stomach.

Authors:  Chun-Hui Li; Li-Hui Pan; Chun-Yu Li; Chang-Lin Zhu; Wen-Xie Xu
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

2.  Remodelling of the intracardiac ganglia in diabetic Goto-Kakizaki rats: an anatomical study.

Authors:  Darius Batulevicius; Thomas Frese; Elmar Peschke; Dainius H Pauza; Vaida Batuleviciene
Journal:  Cardiovasc Diabetol       Date:  2013-06-07       Impact factor: 9.951

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.